E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/29/2008 in the Prospect News Municipals Daily.

Dana-Farber Cancer Institute, Mass., to price $109.305 million revenue bonds

By Cristal Cody

Springdale, Ark., April 29 - The Massachusetts Health and Educational Facilities Authority plans to price $109.305 million revenue bonds for the Dana-Farber Cancer Institute, according to a preliminary official statement.

The series 2008K bonds have serial maturities from Dec. 1, 2008 through Dec. 1, 2024 and term bonds due in 2028 and 2038.

The institute also plans to price $92.745 million series 2008L1 and $91.88 million series 2008L2 variable-rate bonds, according to the statement.

Goldman, Sachs & Co. will manage the negotiated sale.

Proceeds will be used to pay the principal and interest due on bridge financing used to refund series 2004H1 and H2 periodic auction-reset bonds and pay termination fees on swap agreements for the series H bonds.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.